These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2229142)

  • 1. Phase II study of tamoxifen and high-dose retinyl acetate in patients with advanced breast cancer.
    Boccardo F; Canobbio L; Resasco M; Decensi AU; Pastorino G; Brema F
    J Cancer Res Clin Oncol; 1990; 116(5):503-6. PubMed ID: 2229142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-beta, retinoids, and tamoxifen in the treatment of metastatic breast cancer: a phase II study.
    Recchia F; Sica G; de Filippis S; Discepoli S; Rea S; Torchio P; Frati L
    J Interferon Cytokine Res; 1995 Jul; 15(7):605-10. PubMed ID: 7553230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma retinol levels and side effects following high-dose retinyl acetate in breast cancer patients.
    Resasco M; Canobbio L; Trave F; Valenti G; Mazzoni A; Canti G; Boccardo F; Nicolin A
    Anticancer Res; 1988; 8(6):1319-23. PubMed ID: 3218964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of tamoxifen, aminoglutethimide, danazol and medroxyprogesterone acetate in advanced breast cancer.
    Hardy JR; Powles TJ; Judson IR; Sinnett HD; Ashley SE; Coombes RC; Ellin CL
    Eur J Cancer; 1990; 26(7):824-7. PubMed ID: 2145904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination chemo-endocrine therapy of metastatic and stage IV breast cancer with cyclophosphamide, adriamycin, prednisolone and tamoxifen (CAPT)--with special reference to management of brain and liver metastasis].
    Nakamura Y; Kawaguchi M; Hata A; Watanabe H; Ueki Y; Oribe T; Koba F; Takamuku K
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):243-50. PubMed ID: 2919892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma.
    Ingle JN; Suman VJ; Kardinal CG; Krook JE; Mailliard JA; Veeder MH; Loprinzi CL; Dalton RJ; Hartmann LC; Conover CA; Pollak MN
    Cancer; 1999 Mar; 85(6):1284-92. PubMed ID: 10189133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential combination of tamoxifen and high dose medroxyprogesterone acetate: therapeutic and endocrine effects in postmenopausal advanced breast cancer patients.
    Gasparini G; Canobbio L; Galligioni E; Fassio T; Brema F; Crivellari D; Villalta D; Di Fronzo G; Talamini R; Monfardini S
    Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1451-9. PubMed ID: 2960532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of high dose raloxifene in selected patients with advanced breast carcinoma.
    Gradishar W; Glusman J; Lu Y; Vogel C; Cohen FJ; Sledge GW
    Cancer; 2000 May; 88(9):2047-53. PubMed ID: 10813716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial of combined hormone therapy (MAP + TAM) for metastatic breast cancer.
    Pannuti F; Martoni A; Piana E; Tomasi L; Grieco A; Farris A; Saccani F; Baroni M
    Chemioterapia; 1984 Aug; 3(4):211-5. PubMed ID: 6241846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II evaluation of combination chemotherapy plus aminoglutethimide in women with metastatic or recurrent breast carcinoma. An Eastern Cooperative Oncology Group Pilot Study.
    Grem JL; Falkson G; Love RR; Tormey DC
    Am J Clin Oncol; 1988 Oct; 11(5):528-34. PubMed ID: 3177253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer.
    Budd GT; Adamson PC; Gupta M; Homayoun P; Sandstrom SK; Murphy RF; McLain D; Tuason L; Peereboom D; Bukowski RM; Ganapathi R
    Clin Cancer Res; 1998 Mar; 4(3):635-42. PubMed ID: 9533531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study.
    Whitney CW; Brunetto VL; Zaino RJ; Lentz SS; Sorosky J; Armstrong DK; Lee RB;
    Gynecol Oncol; 2004 Jan; 92(1):4-9. PubMed ID: 14751130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group.
    Byrne MJ; Gebski V; Forbes J; Tattersall MH; Simes RJ; Coates AS; Dewar J; Lunn M; Flower C; Gill PG; Stewart J
    J Clin Oncol; 1997 Sep; 15(9):3141-8. PubMed ID: 9294477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prednimustine, methotrexate, 5-fluorouracil, mitoxantrone and tamoxifen for advanced breast cancer in postmenopausal women. A phase II trial.
    Andersson M; Mouridsen HT
    Acta Oncol; 1988; 27(3):235-9. PubMed ID: 3415852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Megestrol acetate in advanced breast carcinoma after failure to tamoxifen and/or aminoglutethimide.
    Brufman G; Isacson R; Haim N; Gez E; Sulkes A
    Oncology; 1994; 51(3):258-61. PubMed ID: 8196908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysis.
    Klaassen U; Wilke H; Pari CP; Strumberg D; Harstrick A; Eberhardt W; Becher R; Diergarten K; Seeber S
    Semin Oncol; 1995 Dec; 22(6 Suppl 14):7-11. PubMed ID: 8553083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
    Goss PE; Clark RM; Ambus U; Weizel HA; Wadden NA; Crump M; Walde D; Tye LM; De Coster R; Bruynseels J
    Clin Cancer Res; 1995 Mar; 1(3):287-94. PubMed ID: 9815984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate and 5-fluorouracil following tamoxifen and premarin in advanced breast cancer.
    Allegra JC
    Semin Oncol; 1983 Jun; 10(2 Suppl 2):23-8. PubMed ID: 6306835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-interferon, retinoids and tamoxifen in metastatic breast cancer: long-term follow-up of a phase II study.
    Recchia F; Sica G; Candeloro G; Necozione S; Bisegna R; Bratta M; Rea S
    Oncol Rep; 2009 Apr; 21(4):1011-6. PubMed ID: 19288002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.